BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32574377)

  • 1. Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study.
    Hodak E; Sherman S; Papadavid E; Bagot M; Querfeld C; Quaglino P; Prince HM; Ortiz-Romero PL; Stadler R; Knobler R; Guenova E; Estrach T; Patsatsi A; Leshem YA; Prague-Naveh H; Berti E; Alberti-Violetti S; Cowan R; Jonak C; Nikolaou V; Mitteldorf C; Akilov O; Geskin L; Matin R; Beylot-Barry M; Vakeva L; Sanches JA; Servitje O; Weatherhead S; Wobser M; Yoo J; Bayne M; Bates A; Dunnill G; Marschalko M; Buschots AM; Wehkamp U; Evison F; Hong E; Amitay-Laish I; Stranzenbach R; Vermeer M; Willemze R; Kempf W; Cerroni L; Whittaker S; Kim YH; Scarisbrick JJ;
    Br J Dermatol; 2021 Mar; 184(3):524-531. PubMed ID: 32574377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography.
    Tsai EY; Taur A; Espinosa L; Quon A; Johnson D; Dick S; Chow S; Advani R; Warnke R; Kohler S; Hoppe RT; Kim YH
    Arch Dermatol; 2006 May; 142(5):577-84. PubMed ID: 16702495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.
    Scarisbrick JJ; Quaglino P; Prince HM; Papadavid E; Hodak E; Bagot M; Servitje O; Berti E; Ortiz-Romero P; Stadler R; Patsatsi A; Knobler R; Guenova E; Child F; Whittaker S; Nikolaou V; Tomasini C; Amitay I; Prag Naveh H; Ram-Wolff C; Battistella M; Alberti-Violetti S; Stranzenbach R; Gargallo V; Muniesa C; Koletsa T; Jonak C; Porkert S; Mitteldorf C; Estrach T; Combalia A; Marschalko M; Csomor J; Szepesi A; Cozzio A; Dummer R; Pimpinelli N; Grandi V; Beylot-Barry M; Pham-Ledard A; Wobser M; Geissinger E; Wehkamp U; Weichenthal M; Cowan R; Parry E; Harris J; Wachsmuth R; Turner D; Bates A; Healy E; Trautinger F; Latzka J; Yoo J; Vydianath B; Amel-Kashipaz R; Marinos L; Oikonomidi A; Stratigos A; Vignon-Pennamen MD; Battistella M; Climent F; Gonzalez-Barca E; Georgiou E; Senetta R; Zinzani P; Vakeva L; Ranki A; Busschots AM; Hauben E; Bervoets A; Woei-A-Jin FJSH; Matin R; Collins G; Weatherhead S; Frew J; Bayne M; Dunnill G; McKay P; Arumainathan A; Azurdia R; Benstead K; Twigger R; Rieger K; Brown R; Sanches JA; Miyashiro D; Akilov O; McCann S; Sahi H; Damasco FM; Querfeld C; Folkes A; Bur C; Klemke CD; Enz P; Pujol R; Quint K; Geskin L; Hong E; Evison F; Vermeer M; Cerroni L; Kempf W; Kim Y; Willemze R
    Br J Dermatol; 2019 Aug; 181(2):350-357. PubMed ID: 30267549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.
    Quaglino P; Prince HM; Cowan R; Vermeer M; Papadavid E; Bagot M; Servitjie O; Berti E; Guenova E; Stadler R; Querfeld C; Busschots AM; Hodak E; Patsatsi A; Sanches J; Maule M; Yoo J; Kevin M; Fava P; Ribero S; Zocchi L; Rubatto M; Fierro MT; Wehkamp U; Marshalko M; Mitteldorf C; Akilov O; Ortiz-Romero P; Estrach T; Vakeva L; Enz PA; Wobser M; Bayne M; Jonak C; Rubeta M; Forbes A; Bates A; Battistella M; Amel-Kashipaz R; Vydianath B; Combalia A; Georgiou E; Hauben E; Hong EK; Jost M; Knobler R; Amitay-Laish I; Miyashiro D; Cury-Martins J; Martinez X; Muniesa C; Prag-Naveh H; Stratigos A; Nikolaou V; Quint K; Ram-Wolff C; Rieger K; Stranzenbach R; Szepesi Á; Alberti-Violetti S; Felicity E; Cerroni L; Kempf W; Whittaker S; Willemze R; Kim Y; Scarisbrick JJ
    Br J Dermatol; 2021 Apr; 184(4):722-730. PubMed ID: 32479678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated review on prognostic factors in mycosis fungoides and new skin lymphoma trials.
    Farabi B; Seminario-Vidal L; Jamgochian M; Akay BN; Atak MF; Rao BK; Karagaiah P; Grabbe S; Goldust M
    J Cosmet Dermatol; 2022 Jul; 21(7):2742-2748. PubMed ID: 34687485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors for the use of systemic therapy in stage IB Mycosis fungoides.
    Rodriguez E; Needle CD; Martinez MJ; Nohria A; Xing Y; Song C; Betensky R; Latkowski JA; Adotama P
    Arch Dermatol Res; 2024 Jun; 316(6):337. PubMed ID: 38844623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphography in the assessment of mycosis fungoides.
    Tallroth K; Wiljasalo M; Valle M; Korhola O
    Lymphology; 1977 Sep; 10(3):147-50. PubMed ID: 592885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.
    Molloy K; Jonak C; Woei-A-Jin FJSH; Guenova E; Busschots AM; Bervoets A; Hauben E; Knobler R; Porkert S; Fassnacht C; Cowan R; Papadavid E; Beylot-Barry M; Berti E; Alberti Violetti S; Estrach T; Matin R; Akilov O; Vakeva L; Prince M; Bates A; Bayne M; Wachsmuch R; Wehkamp U; Marschalko M; Servitje O; Turner D; Weatherhead S; Wobser M; Sanches JA; McKay P; Klemke D; Peng C; Howles A; Yoo J; Evison F; Scarisbrick J
    Br J Dermatol; 2020 Mar; 182(3):770-779. PubMed ID: 31049926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of T-cell receptor gene rearrangement in lymph nodes of patients with mycosis fungoides. Prognostic implications.
    Kern DE; Kidd PG; Moe R; Hanke D; Olerud JE
    Arch Dermatol; 1998 Feb; 134(2):158-64. PubMed ID: 9487207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of DC-LAMP+ mature dendritic cell subsets in dermatopathic lymphadenitis of mycosis fungoides.
    Tada K; Hamada T; Asagoe K; Umemura H; Mizuno-Ikeda K; Aoyama Y; Otsuka M; Yamasaki O; Iwatsuki K
    Eur J Dermatol; 2014; 24(6):670-5. PubMed ID: 25672788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-guided lymph node core-needle biopsy predicts survival in mycosis fungoides and Sézary syndrome.
    Calvani J; de Masson A; de Margerie-Mellon C; de Kerviler É; Ram-Wolff C; Gruber A; Meignin V; Brice P; Sadoux A; Mourah S; Bagot M; Battistella M
    Br J Dermatol; 2021 Aug; 185(2):419-427. PubMed ID: 33400272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
    J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node biopsy in mycosis fungoides.
    Colby TV; Burke JS; Hoppe RT
    Cancer; 1981 Jan; 47(2):351-9. PubMed ID: 7459823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides.
    Scheffer E; Meijer CJ; Van Vloten WA
    Cancer; 1980 Jan; 45(1):137-48. PubMed ID: 7350998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
    Scarisbrick JJ; Kim YH; Whittaker SJ; Wood GS; Vermeer MH; Prince HM; Quaglino P
    Br J Dermatol; 2014 Jun; 170(6):1226-36. PubMed ID: 24641480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study.
    Allen PB; McCook-Veal AA; Switchenko JM; Paulino DM; Niyogusaba T; Baird KM; Tarabadkar ES; Lechowicz MJ
    Cancer; 2023 Feb; 129(4):541-550. PubMed ID: 36523150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients.
    Lebowitz E; Geller S; Flores E; Pulitzer M; Horwitz S; Moskowitz A; Kheterpal M; Myskowski PL
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):108-114. PubMed ID: 30176169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of High-Frequency Ultrasound in Accurate Staging of Mycosis Fungoides/Sézary Syndrome.
    Wang Y; Niu Z; Liu J; Zhu Q; Liu Z; Liu Y; Jin H
    J Ultrasound Med; 2020 Oct; 39(10):1927-1937. PubMed ID: 32319698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.